FDA Filing expected in Q3 for NASDAQ Company’s JW-100 treatment for Eczema; Jupiter Wellness, Inc. (NASDAQ: JUPW)
FDA Filing expected in Q3 for NASDAQ Company’s JW-100 treatment for Eczema; Jupiter Wellness, Inc. (NASDAQ: JUPW) Jupiter Wellness, Inc (NASDAQ:JUPW) JUPITER, FLORIDA, UNITED STATES, June 22, 2021 /EINPresswire.com/ -- FDA Filing expected this Q3 for …